Pay in 4 interest-free payments of $43.88 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
suggesting its therapeutic potential
5-2(4(8)9)1-3(6)7/h3-11
2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile
InChi: InChI=1S/C31H52N2O5S
5-fluorouracil (5-FU)
Tetrabenazine D6 - CAS# 1392826-25-3 Catalog No.:M11057-10 suggesting its therapeutic potentialDeutetrabenazine, also known as SD 809 and Tetrabenazine d6, is an investigational, oral, small molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD 809 is being developed for the treatment of chorea associated with Huntingtons disease, a neurodegenerative movement disorder that impacts
US$ 50.00
US$ 125.00
US$ 40.00
US$ 31.95
US$ 200.00
US$ 90.00
US$ 20.00
US$ 39.99
US$ 15.95
US$ 44.99
US$ 1250.00